AB

Aaron Brinkworth

Resonance Health Limited | Non-Executive Director
Mr Brinkworth had a 22-year career with US headquartered, Nasdaq listed, Gilead Sciences, Inc. (Nasdaq: GILD). Mr Brinkworth held several commercial, licensing, and patient access roles, including that of Executive Director - Gilead Sciences Global Patient Solutions. He has served on the Board of Directors of the Royal Surf Lifesaving Society of Western Australia since 2020.

Company and Role

Company
Title
Tenure
Since
RHT
Resonance Health Limited
  • Non-Executive Director
1yrs, 2mthMar 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RHT
Resonance Health Limited
05/09/23300,000N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RHT
Resonance Health Limited
05/09/23
Buy
300,000$0.066$19,676On-market trade